CELG

T. Rowe Price Associates’s Celgene Corp CELG Stock Holding History

T. Rowe Price Associates’s Portfolio CELG Stock Details CELG Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,302,695	Closed	-$129M	–	2599
2019 Q3	$129M	Sell	1,302,695 -741,178	-36%	-$73.6M	0.02%	545
2019 Q2	$189M	Sell	2,043,873 -1,977,466	-49%	-$183M	0.03%	479
2019 Q1	$379M	Sell	4,021,339 -991,112	-20%	-$93.5M	0.06%	311
2018 Q4	$321M	Sell	5,012,451 -4,902,423	-49%	-$314M	0.05%	319
2018 Q3	$887M	Buy	9,914,874 +6,622,724	+201%	+$593M	0.13%	173
2018 Q2	$261M	Buy	3,292,150 +71,252	+2%	+$5.66M	0.04%	401
2018 Q1	$287M	Sell	3,220,898 -4,962,763	-61%	-$443M	0.05%	377
2017 Q4	$854M	Sell	8,183,661 -3,036,847	-27%	-$317M	0.14%	162
2017 Q3	$1.64B	Sell	11,220,508 -1,153,174	-9%	-$168M	0.28%	83
2017 Q2	$1.61B	Sell	12,373,682 -2,383,169	-16%	-$310M	0.29%	83
2017 Q1	$1.84B	Sell	14,756,851 -1,589,173	-10%	-$198M	0.34%	67
2016 Q4	$1.89B	Sell	16,346,024 -1,661,133	-9%	-$192M	0.38%	64
2016 Q3	$1.88B	Sell	18,007,157 -746,559	-4%	-$78M	0.38%	60
2016 Q2	$1.85B	Sell	18,753,716 -3,044,808	-14%	-$300M	0.39%	54
2016 Q1	$2.18B	Sell	21,798,524 -4,477,414	-17%	-$448M	0.47%	40
2015 Q4	$3.15B	Sell	26,275,938 -1,895,528	-7%	-$227M	0.66%	28
2015 Q3	$3.05B	Buy	28,171,466 +528,991	+2%	+$57.2M	0.68%	25
2015 Q2	$3.2B	Sell	27,642,475 -126,645	-0.5%	-$14.7M	0.66%	24
2015 Q1	$3.2B	Buy	27,769,120 +744,643	+3%	+$85.8M	0.66%	22
2014 Q4	$3.02B	Sell	27,024,477 -188,386	-0.7%	-$21.1M	0.64%	22
2014 Q3	$2.58B	Buy	27,212,863 +563,522	+2%	+$53.4M	0.56%	35
2014 Q2	$2.29B	Buy	26,649,341 +13,450,507	+102%	+$1.16B	0.49%	41
2014 Q1	$1.84B	Sell	13,198,834 -891,072	-6%	-$124M	0.41%	51
2013 Q4	$2.38B	Sell	14,089,906 -250,307	-2%	-$42.3M	0.55%	30
2013 Q3	$2.21B	Buy	14,340,213 +384,013	+3%	+$59.1M	0.55%	32
2013 Q2	$1.63B	Buy	+13,956,200	New	+$1.63B	0.44%	48